Business · 31/05/2016Updated: 10/17/2026 · 1 min read
FDA Renews Psychopharmacologic Drugs Advisory Committee for 2 Years
Summary
The FDA is renewing the Psychopharmacologic Drugs Advisory Committee for an additional 2 years, with the new charter set to expire on June 4, 2018.